Hostname: page-component-cb9f654ff-fg9bn Total loading time: 0 Render date: 2025-08-26T23:18:36.263Z Has data issue: false hasContentIssue false
  • English
  • Français

Current Problems in the Use of the Oncolytic Drugs

Published online by Cambridge University Press:  01 August 2014

James G. Armstrong
James G. Armstrong*
Affiliation:
Lilly Labs. for Clinical Research, Marion County General Hospital, Indianapolis, Ind.

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

1. Lists have been made of the more frequently occurring malignant diseases and of those commonly available oncolytic drugs which, in the author's opinion, are most appropriate for their treatment.

2. Those tumors which do not usually respond to oncolytic drugs have also been listed.

3. For several malignant diseases it has been found that small doses of oncolytic drugs have proved just as effective for inducing remission and even more effective in prolonging remission than have larger doses of these drugs. The explanation for this may be that smaller doses do less harm to the body's immune defense mechanism than do larger doses.

Information

Type
Research Article
Information
Acta geneticae medicae et gemellologiae: twin research , Volume 17 , Issue 1 , January 1968 , pp. 270 - 278
Copyright
Copyright © The International Society for Twin Studies 1968

References

Bibliographie

Costa, G. et al. (1962). Initial clinical studies with Vincristine. Cancer Chemother. Rep., 24: 39.Google Scholar
Finkel, H. E., Yount, W. J. (1966). Low dose Vincristine therapy of reticulum cell sarcoma. 47th Ann. Session Amer. Coll. Phys., New York.Google Scholar
Foley, J. F., Kennedy, B. J. (1964). Effect of cyclophosphamide on far advanced neoplasia. Cancer Chemother. Rep., 34: 55.Google Scholar
Holland, J. F. A current study of the Acute Leukemia Chemotherapy Cooperative Group B. Pers. commun.Google Scholar
Hreschchyshyn, M. M. (1963). Vincristine treatment of patients with carcinoma of the uterine cervix. Proc. Amer. Ass. Cancer Res., 4: 114.Google Scholar
James, D. H. et al. (1964). Chemotherapy of localized inoperable malignant tumors of children. J. Amer. Med. Ass., 189: 636.Google Scholar
Louis, J. A current study of the Midwestern Chemotherapy Cooperative Group. Pers. Commun.Google Scholar
Rundles, W. Pers. Commun.Google Scholar
Selwary, O. S. et al. (1965). New treatment schedule with improved survival in childhood leukemia. J. Amer. Med. Ass., 194: 187.Google Scholar
Thompson, I. et al. (1965). Combination therapy of adult acute myelogenous leukemia: experience with the simultaneous use of Vincristine, Amethopterin, 6-Mercaptopurine and Prednisone. New Engl. J. Med., 273: 1302.CrossRefGoogle ScholarPubMed